Public deck
Bio-Rad Laboratories: Is The Clinical Diagnostics Segment Underpriced Relative To Growth Peers?
Bio-Rad has diagnostics exposure, but the market may be questioning whether the segment deserves a peer-growth multiple.
Public deck
Bio-Rad has diagnostics exposure, but the market may be questioning whether the segment deserves a peer-growth multiple.